Jonathan Mazelsky - IDEXX Laboratories CEO Pres

IX1 Stock  EUR 395.20  5.50  1.37%   

Insider

Jonathan Mazelsky is CEO Pres of IDEXX Laboratories
Age 62
Phone207 556 0300
Webhttps://www.idexx.com

Jonathan Mazelsky Latest Insider Activity

Tracking and analyzing the buying and selling activities of Jonathan Mazelsky against IDEXX Laboratories stock is an integral part of due diligence when investing in IDEXX Laboratories. Jonathan Mazelsky insider activity provides valuable insight into whether IDEXX Laboratories is net buyers or sellers over its current business cycle. Note, IDEXX Laboratories insiders must abide by specific rules, including filing SEC forms every time they buy or sell IDEXX Laboratories'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

IDEXX Laboratories Management Efficiency

The company has return on total asset (ROA) of 0.2167 % which means that it generated a profit of $0.2167 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 1.0458 %, meaning that it generated $1.0458 on every $100 dollars invested by stockholders. IDEXX Laboratories' management efficiency ratios could be used to measure how well IDEXX Laboratories manages its routine affairs as well as how well it operates its assets and liabilities.
IDEXX Laboratories has accumulated 694.39 M in total debt. IDEXX Laboratories has a current ratio of 0.99, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist IDEXX Laboratories until it has trouble settling it off, either with new capital or with free cash flow. So, IDEXX Laboratories' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like IDEXX Laboratories sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for IDEXX to invest in growth at high rates of return. When we think about IDEXX Laboratories' use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 12 records

INSIDER Age

AnneFrederique DujardinJacquet Metal Service
N/A
Sergio MScLion One Metals
N/A
Jens MunchowJacquet Metal Service
N/A
Darren HoldenLion One Metals
N/A
Jeffrey EdelenLion One Metals
N/A
Tony CALion One Metals
N/A
PE MBALion One Metals
64
Arnaud GiulianiJacquet Metal Service
N/A
Stephanie MartelLion One Metals
N/A
HansJosef HossJacquet Metal Service
N/A
Cdric ChaillolJacquet Metal Service
N/A
Alexandre IacovellaJacquet Metal Service
N/A
IDEXX Laboratories, Inc., together with its subsidiaries, develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. IDEXX Laboratories, Inc. was founded in 1983 and is headquartered in Westbrook, Maine. IDEXX Laboratories operates under Diagnostics Research classification in Germany and is traded on Frankfurt Stock Exchange. It employs 8000 people. IDEXX Laboratories (IX1) is traded on Frankfurt Exchange in Germany and employs 10,780 people.

Management Performance

IDEXX Laboratories Leadership Team

Elected by the shareholders, the IDEXX Laboratories' board of directors comprises two types of representatives: IDEXX Laboratories inside directors who are chosen from within the company, and outside directors, selected externally and held independent of IDEXX. The board's role is to monitor IDEXX Laboratories' management team and ensure that shareholders' interests are well served. IDEXX Laboratories' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, IDEXX Laboratories' outside directors are responsible for providing unbiased perspectives on the board's policies.
Sharon Underberg, Gen VP
Ken Grady, VP Officer
Jonathan Mazelsky, CEO Pres
Nimrata PE, Ex Operations
Martin Smith, Ex CTO
James Polewaczyk, Ex Officer
Michael Lane, Ex Technology
John Hart, VP Operations
Jeffery Chadbourne, Director Reporting
Brian McKeon, Ex CFO

IDEXX Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is IDEXX Laboratories a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Additional Information and Resources on Investing in IDEXX Stock

When determining whether IDEXX Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of IDEXX Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Idexx Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Idexx Laboratories Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in IDEXX Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more detail on how to invest in IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.
You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Please note, there is a significant difference between IDEXX Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if IDEXX Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IDEXX Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.